Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Total Debt: 2019-2022

Historic Total Debt for Pharming Group N.V (PHAR) over the last 2 years, with Sep 2022 value amounting to $143,000.

  • Pharming Group N.V's Total Debt fell 62.95% to $143,000 in Q3 2022 from the same period last year, while for Sep 2022 it was $143,000, marking a year-over-year decrease of 99.45%. This contributed to the annual value of $336,593 for FY2021, which is 98.66% down from last year.
  • According to the latest figures from Q3 2022, Pharming Group N.V's Total Debt is $143,000, which was down 5.92% from $152,000 recorded in Q2 2022.
  • In the past 5 years, Pharming Group N.V's Total Debt registered a high of $39.4 million during Q4 2019, and its lowest value of $143,000 during Q3 2022.
  • In the last 3 years, Pharming Group N.V's Total Debt had a median value of $191,602 in 2021 and averaged $3.3 million.
  • Data for Pharming Group N.V's Total Debt shows a maximum YoY crashed of 98.69% (in 2021) over the last 5 years.
  • Quarterly analysis of 4 years shows Pharming Group N.V's Total Debt stood at $39.4 million in 2019, then slumped by 35.98% to $25.2 million in 2020, then plummeted by 98.69% to $330,876 in 2021, then plummeted by 62.95% to $143,000 in 2022.
  • Its last three reported values are $143,000 in Q3 2022, $152,000 for Q2 2022, and $162,000 during Q1 2022.